In what can be said as a big relief to several patients, medicine cost of four rare diseases- Tyrosinemia Type 1, Gaucher’s Disease, Wilson’s Disease, and Dravet-Lennox Gastaut Syndrome- will be less by 100 times with the manufacturing of new medicines.
Get the latest news on GST discussions and find out how the prices of medicines, food, and drinks have been affected. Learn what became cheaper and what became more expensive in the GST meeting.
First-Quarter 2021 Net Sales of $342.4 Million; First-Quarter 2021 GAAP Net Loss of $123.4 Million; Adjusted EBITDA of $45.8 Million First-Quarter 2021 Orphan Segment Net Sales Increased